{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:26:19Z","timestamp":1793755579838,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pan-Provincial Vaccine Enterprise Inc."},{"name":"Vaxent, LLC"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201200003I"],"award-info":[{"award-number":["HHSN272201200003I"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Blood Research Institute"},{"name":"US Public Health Service","award":["RO1 AI-010085"],"award-info":[{"award-number":["RO1 AI-010085"]}]},{"name":"US Public Health Service","award":["RO1 AI-132117"],"award-info":[{"award-number":["RO1 AI-132117"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.12.005","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T18:23:18Z","timestamp":1576261398000},"page":"1384-1392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study"],"prefix":"10.1016","volume":"38","author":[{"given":"\u00c9lodie","family":"Pastural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly A.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"MacKinnon-Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis H.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Penfound","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.12.005_b0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/14760584.2016.1116946","article-title":"Development of Group A streptococcal vaccines: an unmet global health need","volume":"15","author":"Sheel","year":"2016","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.12.005_b0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of Group A streptococcus disease","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.005_b0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and National Burden of Rheumatic Heart Disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.12.005_b0020","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1016\/j.vaccine.2016.02.078","article-title":"Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7\u20139th Sep 2015","volume":"34","author":"Giersing","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.005_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1143","article-title":"The path to group A Streptococcus vaccines: WHO research and development technology roadmap and preferred product characteristics","author":"Vekemans","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.005_b0030","unstructured":"WHO; 2018. https:\/\/www.who.int\/ncds\/management\/rheumatic-heart-disease-resolution\/en\/ [accessed July 24, 2019]."},{"key":"10.1016\/j.vaccine.2019.12.005_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/art.1780100311","article-title":"Prospects for a vaccine against group A streptococci: the problem of the immunology of M proteins","author":"Stollerman","year":"1967","journal-title":"Arthrit Rheum"},{"key":"10.1016\/j.vaccine.2019.12.005_b0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/am.16.3.509-518.1968","article-title":"Secondary and apparent primary antibody responses after group A streptococcal vaccination of 21 children","volume":"16","author":"Massell","year":"1968","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2019.12.005_b0045","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jama.1969.03150190037007","article-title":"Rheumatic fever following streptococcal vaccination. Report of three cases","volume":"207","author":"Massell","year":"1969","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2019.12.005_b0050","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.4049\/jimmunol.151.4.2188","article-title":"Recombinant tetravalent group A streptococcal M protein vaccine","volume":"151","author":"Dale","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.12.005_b0055","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0264-410X(96)00050-3","article-title":"Recombinant, octavalent group A streptococcal M protein vaccine","volume":"14","author":"Dale","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.005_b0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"Dale","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.005_b0065","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.12.005_b0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"Kotloff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.12.005_b0075","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.005_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ics.2005.12.002","article-title":"A double-blind, randomized, phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults","volume":"1289","author":"McNeil","year":"2005","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.vaccine.2019.12.005_b0085","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.005_b0090","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00413-10","article-title":"Novel, versatile, and tightly regulated expression system for Escherichia coli Strains","volume":"76","author":"Choi","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2019.12.005_b0095","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.72.5.2507-2512.2004","article-title":"Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections","volume":"72","author":"Hall","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.12.005_b0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1084\/jem.106.4.525","article-title":"Differentiation of group A streptococci with a common R antigen into three serologic types with special reference to the bactericidal test","volume":"106","author":"Lancefield","year":"1957","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.12.005_b0105","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00617-18","article-title":"Development of an opsonophagocytic killing assay using HL-60 cells for detection of functional antibodies against Streptococcus pyogenes","volume":"3","author":"Salehi","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2019.12.005_b0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0891-5520(05)70052-0","article-title":"Multivalent group A streptococcal vaccines","volume":"13","author":"Dale","year":"1999","journal-title":"Inf Dis Clin N Amer"},{"key":"10.1016\/j.vaccine.2019.12.005_b0115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.vaccine.2013.01.019","article-title":"Potential coverage of a multivalent M protein-based group A streptococcal vaccine","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.005_b0120","article-title":"Streptococcal pharyngitis in schoolchildren in Bamako, Mali","author":"Tapia","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.005_b0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/INF.0b013e3182a5c32a","article-title":"Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage","volume":"33","author":"Engel","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.005_b0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2016.11.065","article-title":"Structure-based design of broadly protective group a streptococcal M protein-based vaccines","volume":"35","author":"Dale","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.005_b0135","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/jiu260","article-title":"A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development","volume":"210","author":"Sanderson-Smith","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.005_b0140","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/cid\/cix599","article-title":"Immune cross-opsonization within emm clusters following group A streptococcus skin infection: broadening the scope of type-specific immunity","volume":"65","author":"Frost","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.005_b0145","doi-asserted-by":"crossref","first-page":"e0198658","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:45Z","timestamp":1759401645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316457"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}